| Literature DB >> 28235084 |
Larissa Ferreira-Santos1,2, Daniel G Martinez3, José Carlos Nicolau1, Humberto G Moreira1, Maria Janieire Alves1, Alexandre C Pereira1, Ivani C Trombetta4, Carlos Eduardo Negrão1,2, Maria Urbana P B Rondon2.
Abstract
BACKGROUND: Gln27Glu (rs1042714) polymorphism of the β2-adrenergic receptor (ADRB2) has been association with cardiovascular functionality in healthy subjects. However, it is unknown whether the presence of the ADRB2 Gln27Glu polymorphism influences neurovascular responses during exercise in patients with acute coronary syndromes (ACS). We tested the hypothesis that patients with ACS homozygous for the Gln allele would have increased muscle sympathetic nerve activity (MSNA) responses and decreased forearm vascular conductance (FVC) responses during exercise compared with patients carrying the Glu allele (Gln27Glu and Glu27Glu). In addition, exercise training would restore these responses in Gln27Gln patients. METHODS ANDEntities:
Mesh:
Substances:
Year: 2017 PMID: 28235084 PMCID: PMC5325615 DOI: 10.1371/journal.pone.0173061
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Physical and clinical characteristics in patients with polymorphisms Gln27Gln and Gln27Glu+Glu27Glu one month after the ischemic event.
| Gln27Gln (n = 35) | Gln27Glu+Glu27Glu (n = 26) | ||
|---|---|---|---|
| Sex, men (%) | 26 (74) | 19 (73) | 0.92 |
| Age, years | 53±1 | 52±1 | 0.69 |
| Weight, kg | 76.6±2.2 | 80.5±3.0 | 0.29 |
| Height, cm | 1.67±0.02 | 1.69±0.02 | 0.43 |
| BMI, kg/m2 | 27±1 | 28±1 | 0.45 |
| LVEF, % | 57±1 | 59±2 | 0.30 |
| Unstable Angina | 4 (11) | 4 (15) | 0.65 |
| NSTEMI | 12 (34) | 15 (58) | 0.07 |
| STEMI | 19 (54) | 7 (27) | 0.03 |
| Coronary angiography | 35 (100) | 26 (100) | 1.00 |
| 1 stent | 29 (83) | 19 (73) | 0.37 |
| 2 stents | 2 (6) | 2 (8) | 0.71 |
| 3 stents | 1 (3) | 0 (0) | 0.39 |
| β-adrenergic blocker | 32 (91) | 25 (96) | 0.46 |
| ACE/AT1 inhibitor | 34 (97) | 25 (96) | 0.83 |
| Antiplatelet therapy | 35 (100) | 26 (100) | 1.00 |
| Statin | 30 (86) | 24 (92) | 0.42 |
Values are mean±SE. BMI, body mass index; LVEF, left ventricular ejection fraction; NSTEMI, non-ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; ACE, angiotensin-converting enzyme; AT, angiotensin.
Hemodynamic and neurovascular characteristics at baseline and during the handgrip exercise in patients with polymorphisms Gln27Gln and Gln27Glu+Glu27Glu one month after the ischemic event.
| Gln27Gln (n = 35) | Gln27Glu+Glu27Glu (n = 26) | |||||
|---|---|---|---|---|---|---|
| Baseline | 3 min ex | Delta | Baseline | 3 min ex | Delta | |
| 96±2 | 120±3 | 24±2 | 101±2 | 119±2 | 18±2 | |
| 54±1 | 62±2 | 8±1 | 54±2 | 62±1 | 7±1 | |
| 59±3 | 70±3 | 11±2 | 64±3 | 68±4 | 4±2 | |
| 1.53±0.07 | 2.07±0.11 | 0.54±0.08 | 1.64±0.11 | 2.16±0.13 | 0.51±0.06 | |
| 1.63±0.07 | 1.78±0.10 | 0.15±0.08 | 1.63±0.11 | 1.79±0.10 | 0.16±0.07 | |
Values are mean±SE. MBP, mean blood pressure; HR, heart rate; MSNA, muscle sympathetic nerve activity; FBF, forearm blood flow; FVC, forearm vascular conductance.
*P<0.05 vs. baseline (2-way ANOVA for repeated measurements).
†P<0.05 vs. Gln27Gln (delta analysis, unpaired t-test).
Fig 1Muscle Sympathetic Nerve Activity (MSNA) at baseline and during handgrip exercise one month after the ischemic event.
MSNA in burst frequency (bursts/min) at baseline and during handgrip exercise (A), and the MSNA response (Delta, B) in patients with polymorphisms Gln27Gln and Gln27Glu+Glu27Glu. Note that MSNA increased in both groups during the handgrip exercise, but the MSNA response in the Gln27Gln group is significantly higher compared with that in the Gln27Glu+Glu27Glu group. *P<0.05, difference vs. baseline; †P<0.05, difference vs. Gln27Gln.
Fig 2Muscle Sympathetic Nerve Activity (MSNA) pre- and postexercise training period.
Individual data for MSNA in burst frequency (bursts/min) at baseline and during the handgrip exercise and the MSNA response (Delta) in patients with polymorphism Gln27Gln (n = 17, 2A and 2C, respectively) and Gln27Glu+Glu27Glu (n = 08, 2B and 2D, respectively), pre- and postexercise training period. Note that the MSNA significantly decreased after the exercise training period at baseline and during exercise in the Gln27Gln group. *P<0.05, vs. baseline; †P<0.05, vs. preintervention.
Hemodynamic and neurovascular characteristics at baseline and during handgrip exercise in patients with polymorphisms Gln27Gln and Gln27Glu+Glu27Glu before and after the exercise training period.
| Gln27Gln (n = 17) | Gln27Glu+Glu27Glu (n = 08) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | 3 min ex | Delta | Baseline | 3 min ex | Delta | ||
| 98±3 | 122±4 | 24±3 | 100±3 | 119±3 | 19±3 | ||
| 98±2 | 120±3 | 22±3 | 103±4 | 115±3 | 11±2 | ||
| 53±1 | 60±2 | 7±2 | 55±3 | 63±3 | 7±2 | ||
| 53±2 | 59±2 | 7±1 | 53±3 | 58±2 | 5±2 | ||
| 62±4 | 74±4 | 12±2 | 68±4 | 75±4 | 7±3 | ||
| 47±5 | 53±4 | 5±2 | 55±6 | 62±7 | 7±3 | ||
| 1.77±0.10 | 2.13±0.18 | 0.37±0.08 | 1.64±0.10 | 2.24±0.17 | 0.59±0.11 | ||
| 1.70±0.13 | 2.19±0.17 | 0.50±0.07 | 1.89±0.24 | 2.53±0.33 | 0.64±0.15 | ||
| 1.78±0.10 | 1.73±0.13 | -0.05±0.08 | 1.66±0.12 | 1.89±0.12 | 0.23±0.09 | ||
| 1.76±0.12 | 1.83±0.15 | 0.07±0.08 | 1.58±0.20 | 2.10±0.24 | 0.53±0.19 | ||
Values are mean±SE. MBP, mean blood pressure; HR, heart rate; MSNA, muscle sympathetic nerve activity; FBF, forearm blood flow; FVC, forearm vascular conductance; Pre, preintervention period; Post, after exercise training period.
# P<0.05, within-group comparisons vs. preintervention (two-way ANOVA for repeated measurements).
*P<0.05, within-group comparisons vs. baseline.
†P<0.05, between-group comparisons (delta analysis, unpaired t-test).
Fig 3Muscle Sympathetic Nerve Activity (MSNA) response in the postexercise training period.
MSNA response (delta) in bursts/min in the postexercise training period in patients with the polymorphism Gln27Gln (n = 17) and in the Gln27Glu+Glu27Glu group (n = 08). Note that MSNA response was similar in both groups after the exercise training period.